Bio Pharma Engineering Limited was set up on Friday the 29th of September 2006. Their current partial address is Cork, and the company status is Normal. The company's current directors have been the director of 1 other Irish company between them; 1 of which is now closed. Bio Pharma Engineering Limited has 1 shareholder. This Irish company shares its Eircode with at least 19 other companies.
| Company Name: | Bio Pharma Engineering Limited |
| Company Status: | NORMAL |
| Company Address: | Nsc Campus, Mahon, Co. Cork,Cork |
| Telephone: | +353 (0)21 230 7120 |
| Website: | www.biopharma.ie |
| Key Executive: | Mr O'Reilly |
| Company Size: | Log-In To View |
| Disclaimer | Other Details |
|---|---|
| Please note the contact details displayed above are collected from a variety of public sources and are appended to this report for your convenience. As they are non-CRO data, we can not vouch for their accuracy or timeliness. To update contact details on this company simply email us. | |
Mr O'Reilly is a Company Director of Bio Pharma Engineering Limited since 2006 and a listed Director of 1 other companies.
Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.
Similar Companies - Create a marketing list of similar companies
The latest documents filed with the Companies Registration Office for Bio Pharma Engineering Limited (which can include the Account Details) are listed below.
| CRO Document | Effective Date | Received By CRO | View Now | |
|---|---|---|---|---|
| Form B1C - Annual Return General | 21/06/2022 | 10/08/2022 | Join Up | |
| FINANCIAL STATEMENT | 21/06/2022 | 10/08/2022 | Join Up | |
| OTHER DIRECTORSHIP LIST | 21/06/2022 | 10/08/2022 | Join Up | |
| B10 CHANGE IN DIRECTORS/SECRETARY | 30/11/2021 | 12/01/2022 | Join Up | |
| OTHER DIRECTORSHIP LIST | 30/11/2021 | 12/01/2022 | Join Up | |
| THIS COMPANY HAS 57 OTHER DOCS » | ||||
View CRO company documents and company reports any Irish company or business with ease.
View the Latest Credit Report and Credit Limit on Bio Pharma Engineering Limited.
| Company Status: | Normal |
| Latest Credit Movement: |  |
| Date of Last Movement: | 12/08/2022 |
| Latest Accounts Filed: | 10/08/2022 |
| Report Based on Accounts: | 31/12/2021 |
| Next Set of Accounts Due: | 21/06/2023 |
| Overdue: | No |
| Credit Score: | Join-Up to View |
To View the latest Credit Rating or Credit Limit on Bio Pharma Engineering Limited simply click 'Log-In' or 'Join-Up' below.
Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.
Satisfy due diligence requirements on Bio Pharma Engineering Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Bio Pharma Engineering Limited and Anti-Money Laundering checks (AML checks) on Bio Pharma Engineering Limited
| Company Type: | LTD - Private Company Limited By Shares |
| Number of Shareholders: | 1 |
Log-in now to run Due Diligence checks and Compliance checks on Bio Pharma Engineering Limited or click Join-up to get started.
Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.
More people choose Vision-net over any other search service... ask us why?
28/11/2022
Companies across Europe are now beginning to change their behaviour in order to comply with a new directive issued by the European Commission (CSRD). Prior to this, companies opted to become more sustainable for reputational reasons.
22/11/2022
Being a sustainable business now brings many advantages both environmentally and commercially.
11/11/2022
Companies around Ireland are completing risk management assessments now more than ever, due to the predicted volatility of the economy in the months ahead.
04/11/2022
Assessing sole traders and new small businesses is an age old issue.For years, this has resulted in companies having to write-off bad debts, from not having an easy way to assess and monitor a sole trader's ability to repay.
